2 weeks Ago By ABMN Staff
Legal & General Group Plc lowered its stake in Enovix Co. ( NASDAQ:ENVX – Free Report ) by 7.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission.
The institutional investor owned 150,584 shares of the company’s stock after selling 12,675 shares during the quarter. Legal & General Group Plc owned about 0.08% of Enovix worth $1,637,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. Fifth Third Bancorp boosted its position in shares of Enovix by 66.7% during the 4th quarter.
Fifth Third Bancorp now owns 2,500 shares of the company’s stock valued at $27,000 after acquiring an additional 1,000 shares during the last quarter. Sava Infond d.o.
o. purchased a new position in shares of Enovix in the 4th quarter worth $43,000. Hollencrest Capital Management raised its position in shares of Enovix by 61.
4% during the 4th quarter. Hollencrest Capital Management now owns 5,256 shares of the company’s stock valued at $57,000 after buying an additional 2,000 shares in the last quarter. R Squared Ltd purchased a new position in Enovix in the fourth quarter worth about $64,000.
Finally, Lee Danner & Bass Inc. bought a new stake in Enovix during the fourth quarter worth approximately $65,000. 50.
92% of the stock is owned by institutional investors. Wall Street Analysts Forecast Growth A number of equities analysts have recently commented on ENVX shares. Craig Hallum dropped their target price on Enovix from $20.
00 to $18.00 and set a “buy” rating for the company in a report on Thursday, February 20th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $30.
00 price objective on shares of Enovix in a research note on Thursday, February 20th. JPMorgan Chase & Co. cut their price objective on shares of Enovix from $15.
00 to $10.00 and set an “overweight” rating on the stock in a research report on Thursday. Finally, Benchmark dropped their price target on shares of Enovix from $25.
00 to $15.00 and set a “buy” rating for the company in a research note on Tuesday, April 15th. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock.
Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $18.80. Insider Buying and Selling In other news, CEO Rajendra K.
Talluri sold 300,000 shares of the company’s stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $9.35, for a total value of $2,805,000.
00. Following the completion of the sale, the chief executive officer now owns 2,045,301 shares of the company’s stock, valued at approximately $19,123,564.35.
This represents a 12.79 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link .
15.70% of the stock is owned by insiders. Enovix Price Performance Enovix stock opened at $6.
84 on Friday. The company has a debt-to-equity ratio of 0.99, a current ratio of 3.
77 and a quick ratio of 3.61. The stock has a market cap of $1.
31 billion, a price-to-earnings ratio of -4.72 and a beta of 1.98.
The firm has a 50-day moving average of $7.64 and a two-hundred day moving average of $9.54.
Enovix Co. has a 1 year low of $5.27 and a 1 year high of $18.
68. Enovix ( NASDAQ:ENVX – Get Free Report ) last announced its quarterly earnings data on Wednesday, February 19th. The company reported ($0.
17) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.18) by $0.01.
Enovix had a negative return on equity of 96.99% and a negative net margin of 963.17%.
The company had revenue of $9.72 million for the quarter, compared to analysts’ expectations of $8.77 million.
On average, research analysts forecast that Enovix Co. will post -1.01 earnings per share for the current year.
About Enovix ( Free Report ) Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
See Also Want to see what other hedge funds are holding ENVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovix Co. ( NASDAQ:ENVX – Free Report ).
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter ..
